Drugs / rec-LH
last change Dec 2010 re-read 2 minutes ago

rec-LH

Protein / enzyme biologic

Developed for
pregnancy disorder
Investigated by
Merck Serono International SA · University Hospital Brussels

Trials 1 · a red edge is where a trial was stopped

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00954811 Sep 2005 → Jan 2008 pregnancy disorder with abortive outcome University Hospital Brussels Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rec-LH ClinicalTrials.gov intervention name — accepted as the source's own label NCT00954811
Modality Protein / enzyme biologic “recombinant LH 1505” NCT00954811